Page URL: https://www.bionews.org.uk/page_2519

CRISPR/Cas9

A genome-editing platform that uses an enzyme (Cas9) to make a double-stranded break at a specific location in the genome, directed by a guide RNA.

Articles using this Glossary Item

Page 1 of 9
New study on CRISPR: the stake of unintended consequences in embryos 23 November 2020 Comment
Safer, targeted method to deliver CRISPR genome therapy developed 16 November 2020 News
Study shows risks of using genome editing on embryos 2 November 2020 News
Powerful new CRISPR approach allows larger genome edits 26 October 2020 News
A pathway to nowhere? A critique of the National Academy of Sciences report on genome editing 12 October 2020 Comment
CRISPR genome editing pioneers win Nobel prize in chemistry 12 October 2020 News
CRISPR genome editing improved by enzyme testing 14 September 2020 News
New report gives guidance on genome editing for heritable diseases 7 September 2020 News
Epigenetic factors control mouse embryo development 3 August 2020 News
Discovery of a tiny CRISPR protein perfect for human genome editing 27 July 2020 News
Genome editing in mitochondria finally possible 13 July 2020 News
Genome editing in human embryos has unintended side-effects 29 June 2020 News
CRISPR trial shows promising results for sickle cell and thalassaemia 22 June 2020 News
Organoids used to study ovarian cancer 1 June 2020 News
Diabetes reversed in mice using CRISPR and stem cell therapy 27 April 2020 News
New Cas9 variant reduces off-target CRISPR effects 9 March 2020 News
New CRISPR tool to visualise cells in human organoids 9 March 2020 News
Event Review: The Gene Gap – Who would you trust to edit the human race? 17 February 2020 Review
Improved base-editors advance CRISPR based genome editing 17 February 2020 News
CRISPR-edited cells for cancer treatment appear safe 10 February 2020 News
Page 1 of 9

Events using this Glossary Item

Page 1 of 0